Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity

Journal of Autoimmunity

Volumn 36, Issue 1, 2011, Pages 56-64

  Wu, Gregory F ^a   Shindler, Kenneth S ^a   Allenspach, Eric J ^a   Stephen, Tom L ^a   Thomas, Hannah L ^a   Mikesell, Robert J ^b   Cross, Anne H ^b   Laufer, Terri M ^a,c,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d 753 BRB II/III 421 Curie Blvd ^*  (United States)

Author keywords

Antigen presenting cells; Autoimmunity; Dendritic cells; Experimental autoimmune encephalomyelitis MS; Immunopathology; Neuroimmunology

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 17; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE PREDISPOSITION; FEMALE; IMMUNIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NEWBORN; NONHUMAN; OPTIC NEURITIS; PRIORITY JOURNAL; RADIOSENSITIVITY;

ANIMALS; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OPTIC NERVE; SPINAL CORD;

EID: 79151481102     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.10.006     Document Type: Article

References (50)

1. Steinman L. Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron 1999, 24:511-514.
2. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240.
3. Steinman L., Solomon D., Lim M., Zamvil S., Sriram S. Prevention of experimental allergic encephalitis with in vivo administration of anti I-A antibody. Decreased accumulation of radiolabelled lymph node cells in the central nervous system. J Neuroimmunol 1983, 5:91-97.
4. Becher B., Bechmann I., Greter M. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J Mol Med 2006, 84:532-543.
5. Greter M., Heppner F.L., Lemos M.P., Odermatt B.M., Goebels N., Laufer T., et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med 2005, 11:328-334.
6. Matsushita T., Yanaba K., Bouaziz J.D., Fujimoto M., Tedder T.F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 2008.
7. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
8. Heppner F.L., Greter M., Marino D., Falsig J., Raivich G., Hovelmeyer N., et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med 2005, 11:146-152.
9. Fillatreau S., Gray D., Anderton S.M. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol 2008, 8:391-397.
10. Bettelli E., Baeten D., Jager A., Sobel R.A., Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J Clin Invest 2006, 116:2393-2402.
11. Hauser S.L., Waubant E., Arnold D.L., Vollmer T., Antel J., Fox R.J., et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008, 358:676-688.
12. Weber M.S., Prod'homme T., Patarroyo J.C., Molnarfi N., Karnezis T., Lehmann-Horn K., et al. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann Neurol 2010, 68:369-383.
13. Oliver A.R., Lyon G.M., Ruddle N.H. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. J Immunol 2003, 171:462-468.
14. Lyons J.A., San M., Happ M.P., Cross A.H. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur J Immunol 1999, 29:3432-3439.
15. Bailey S.L., Schreiner B., McMahon E.J., Miller S.D. CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. Nat Immunol 2007, 8:172-180.
16. McMahon E.J., Bailey S.L., Castenada C.V., Waldner H., Miller S.D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 2005, 11:335-339.
17. Wu G.F., Laufer T.M. The role of dendritic cells in multiple sclerosis. Curr Neurol Neurosci Rep 2007, 7:245-252.
18. Hawiger D., Masilamani R.F., Bettelli E., Kuchroo V.K., Nussenzweig M.C. Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo. Immunity 2004, 20:695-705.
19. Lemos M.P., Fan L., Lo D., Laufer T.M. CD8alpha+ and CD11b+ dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity. J Immunol 2003, 171:5077-5084.
20. Lindquist R.L., Shakhar G., Dudziak D., Wardemann H., Eisenreich T., Dustin M.L., et al. Visualizing dendritic cell networks in vivo. Nat Immunol 2004, 5:1243-1250.
21. Grusby M.J., Johnson R.S., Papaioannou V.E., Glimcher L.H. Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science 1991, 253:1417-1420.
22. Allenspach E.J., Lemos M.P., Porrett P.M., Turka L.A., Laufer T.M. Migratory and Lymphoid-resident dendritic cells cooperate to efficiently prime Naive CD4 T cells. Immunity 2008.
23. Racke M.K. Experimental autoimmune encephalomyelitis (EAE). Curr Protoc Neurosci 2001, Chapter 9: Unit9 7.
24. Lemos M.P., Esquivel F., Scott P., Laufer T.M. MHC class II expression restricted to CD8alpha+ and CD11b+ dendritic cells is sufficient for control of Leishmania major. J Exp Med 2004, 199:725-730.
25. Shindler K.S., Guan Y., Ventura E., Bennett J., Rostami A. Retinal ganglion cell loss induced by acute optic neuritis in a relapsing model of multiple sclerosis. Mult Scler 2006, 12:526-532.
26. Shao H., Huang Z., Sun S.L., Kaplan H.J., Sun D. Myelin/oligodendrocyte glycoprotein-specific T-cells induce severe optic neuritis in the C57BL/6 mouse. Invest Ophthalmol Vis Sci 2004, 45:4060-4065.
27. Bishop G.A., Ramirez L.M., Koretzky G.A. Growth inhibition of a B cell clone mediated by ligation of IL-4 receptors or membrane IgM. J Immunol 1993, 150:2565-2574.
28. Miller J.F. Fate of subcutaneous thymus grafts in thymectomized mice inoculated with leukaemic filtrate. Nature 1959, 184(Suppl. 23):1809-1810.
29. Mombaerts P., Clarke A.R., Rudnicki M.A., Iacomini J., Itohara S., Lafaille J.J., et al. Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature 1992, 360:225-231.
30. Kroenke M.A., Carlson T.J., Andjelkovic A.V., Segal B.M. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med 2008, 205:1535-1541.
31. Stromnes I.M., Cerretti L.M., Liggitt D., Harris R.A., Goverman J.M. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat Med 2008, 14:337-342.
32. Slavin A.J., Soos J.M., Stuve O., Patarroyo J.C., Weiner H.L., Fontana A., et al. Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity. J Clin Invest 2001, 108:1133-1139.
33. Tompkins S.M., Padilla J., Dal Canto M.C., Ting J.P., Van Kaer L., Miller S.D. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J Immunol 2002, 168:4173-4183.
34. Ponomarev E.D., Shriver L.P., Maresz K., Dittel B.N. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J Neurosci Res 2005, 81:374-389.
35. Crawford A., Macleod M., Schumacher T., Corlett L., Gray D. Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells. J Immunol 2006, 176:3498-3506.
36. Gapin L., Bravo de Alba Y., Casrouge A., Cabaniols J.P., Kourilsky P., Kanellopoulos J. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model. J Immunol 1998, 160:1555-1564.
37. Williams G.S., Oxenius A., Hengartner H., Benoist C., Mathis D. CD4+ T cell responses in mice lacking MHC class II molecules specifically on B cells. Eur J Immunol 1998, 28:3763-3772.
38. Bettelli E., Pagany M., Weiner H.L., Linington C., Sobel R.A., Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med 2003, 197:1073-1081.
39. Kawamura K., McLaughlin K.A., Weissert R., Forsthuber T.G. Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice. J Immunol 2008, 181:3202-3211.
40. Lovitch S.B., Esparza T.J., Schweitzer G., Herzog J., Unanue E.R. Activation of type B T cells after protein immunization reveals novel pathways of in vivo presentation of peptides. J Immunol 2007, 178:122-133.
41. Genain C.P., Nguyen M.H., Letvin N.L., Pearl R., Davis R.L., Adelman M., et al. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest 1995, 96:2966-2974.
42. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002, 3:944-950.
43. Matsushita T., Horikawa M., Iwata Y., Tedder T.F. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol 2010, 185:2240-2252.
44. Kap Y.S., van Driel N., Blezer E., Parren P.W., Bleeker W.K., Laman J.D., et al. Late B cell depletion with a human anti-human CD20 IgG1kappa monoclonal antibody halts the development of experimental autoimmune encephalomyelitis in marmosets. J Immunol 2010, 185:3990-4003.
45. Deshpande P., King I.L., Segal B.M. Cutting edge: CNS CD11c+ cells from mice with encephalomyelitis polarize Th17 cells and support CD25+CD4+ T cell-mediated immunosuppression, suggesting dual roles in the disease process. J Immunol 2007, 178:6695-6699.
46. Furtado G.C., Pina B., Tacke F., Gaupp S., van Rooijen N., Moran T.M., et al. A novel model of demyelinating encephalomyelitis induced by monocytes and dendritic cells. J Immunol 2006, 177:6871-6879.
47. Zozulya A.L., Clarkson B.D., Ortler S., Fabry Z., Wiendl H. The role of dendritic cells in CNS autoimmunity. J Mol Med 2010, 88:535-544.
48. Bailey-Bucktrout S.L., Caulkins S.C., Goings G., Fischer J.A., Dzionek A., Miller S.D. Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. J Immunol 2008, 180:6457-6461.
49. Irla M., Kupfer N., Suter T., Lissilaa R., Benkhoucha M., Skupsky J., et al. MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity. J Exp Med 2010, 207:1891-1905.
50. Isaksson M., Ardesjo B., Ronnblom L., Kampe O., Lassmann H., Eloranta M.L., et al. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE. Eur J Immunol 2009, 39:2925-2935.